Metformin for the Treatment of the Polycystic Ovary Syndrome

Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)

Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011

Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin

(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011

Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., Gordon, D. J., Krauss, R. M., Savage, P. J., Smith, S. C., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.169404 · Cited by 11,961

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)

The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138

Profound Peripheral Insulin Resistance, Independent of Obesity, in Polycystic Ovary Syndrome

Dunaif, A., Segal, K. R., Futterweit, W., & Dobrjansky, A. (1989) · Diabetes · doi:10.2337/diab.38.9.1165 · Cited by 1,967

The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1)

Ramachandran, A., Snehalatha, C., Mary, S., Mukesh, B., Bhaskar, A. D., Vijay, V., & Indian Diabetes Prevention Programme (IDPP) (2006) · Diabetologia · doi:10.1007/s00125-005-0097-z · Cited by 1,881

Prevalence of the Polycystic Ovary Syndrome in Unselected Black and White Women of the Southeastern United States: A Prospective Study

Knochenhauer, E. S., Key, T. J., Kahsar-Miller, M., Waggoner, W., Boots, L. R., & Azziz, R. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.9.5090 · Cited by 1,759

Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: A prospective, controlled study in 254 affected women

Legro, R. S. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.1.165 · Cited by 1,743

Metformin

Bailey, C. J., & Turner, R. C. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602293340906 · Cited by 1,726

Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement Executive Summary

Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., Gordon, D. J., Krauss, R. M., Savage, P. J., Smith, S. C., et al. (2005) · Cardiology in Review · doi:10.1097/01.crd.0000380842.14048.7e · Cited by 1,600

Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications

Diamanti-Kandarakis, E., & Dunaif, A. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1034 · Cited by 1,947

Metformin: historical overview

Bailey, C. J. (2017) · Diabetologia · doi:10.1007/s00125-017-4318-z · Cited by 1,131

Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis

DeCensi, A., Puntoni, M., Goodwin, P., Cazzaniga, M., Gennari, A., Bonanni, B., & Gandini, S. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0157 · Cited by 918

Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies

Sanchez-Garrido, M. A., & Tena-Sempere, M. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.01.001 · Cited by 557

Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals

Lee, M.-S., Hsu, C.-C., Wahlqvist, M. L., Tsai, H.-N., Chang, Y.-H., & Huang, Y.-C. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-20 · Cited by 380

Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: A comprehensive review

Palomba, S., Falbo, A., Zullo, F., & Orio, F. (2009) · Endocrine Reviews · doi:10.1210/er.2008-0030 · Cited by 426

Metformin Therapy and Risk of Cancer in Patients with Type 2 Diabetes: Systematic Review

Franciosi, M., Lucisano, G., Lapice, E., Strippoli, G. F. M., Pellegrini, F., & Nicolucci, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071583 · Cited by 428

Insulin and hyperandrogenism in women with polycystic ovary syndrome

Baptiste, C. G., Battista, M., Trottier, A., & Baillargeon, J. (2009) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2009.12.010 · Cited by 368

Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis

Naderpoor, N., Shorakae, S., de Courten, B., Misso, M. L., Moran, L. J., & Teede, H. J. (2015) · Human Reproduction Update · doi:10.1093/humupd/dmv025 · Cited by 334

Metformin Use and All-Cause and Prostate Cancer–Specific Mortality Among Men With Diabetes

Margel, D., Urbach, D. R., Lipscombe, L. L., Bell, C. M., Kulkarni, G. S., Austin, P. C., & Fleshner, N. E. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.46.7043 · Cited by 275

Exercise therapy in polycystic ovary syndrome: a systematic review

Harrison, C. L., Lombard, C. B., Moran, L. J., & Teede, H. J. (2011) · Human Reproduction Update · doi:10.1093/humupd/dmq045 · Cited by 267

Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis

Naderpoor, N., Shorakae, S., de Courten, B. V., Misso, M. L., Moran, L., & Teede, H. J. (2016) · Human Reproduction Update · doi:10.1093/humupd/dmv063 · Cited by 257

Metformin, the Aspirin of the 21st Century: Its Role in Gestational Diabetes Mellitus, Prevention of Preeclampsia and Cancer, and the Promotion of Longevity

Romero, R., Erez, O., Hüttemann, M., Maymon, E., Panaitescu, B., Conde-Agudelo, A., Pacora, P., Yoon, B. H., & Grossman, L. I. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.06.003 · Cited by 253

The antidiabetic drug metformin suppresses HER2 (erbB-2) oncoprotein overexpression via inhibition of the mTOR effector p70S6K1 in human breast carcinoma cells

Vazquez-Martin, A., Oliveras-Ferraros, C., & Menendez, J. A. (2009) · Cell Cycle · doi:10.4161/cc.8.1.7499 · Cited by 250

Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome

Diamanti‐Kandarakis, E., Christakou, C. D., Kandaraki, E., & Economou, F. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0733 · Cited by 251

Dual Effect of Metformin on Breast Cancer Proliferation in a Randomized Presurgical Trial

Bonanni, B., Puntoni, M., Cazzaniga, M., Pruneri, G., Serrano, D., Guerrieri‐Gonzaga, A., Gennari, A., Trabacca, M. S., Galimberti, V. E., Veronesi, P., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.3769 · Cited by 246

Gestational diabetes risk factors and long-term consequences for both mother and offspring: a literature review

Farahvar, S., Walfisch, A., & Sheiner, E. (2018) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2018.1476135 · Cited by 245

Effect of a Low Glycemic Index Compared with a Conventional Healthy Diet on Polycystic Ovary Syndrome

Marsh, K. A., Steinbeck, K. S., Atkinson, F. S., Petocz, P., & Brand-Miller, J. C. (2010) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2010.29261 · Cited by 228

Therapeutic options for management of endometrial hyperplasia

Chandra, V., Kim, J.-J., Benbrook, D. M., Dwivedi, A., & Rai, R. (2015) · Journal of Gynecologic Oncology · doi:10.3802/jgo.2016.27.e8 · Cited by 224

Insulin resistance, obesity, inflammation, and depression in polycystic ovary syndrome: biobehavioral mechanisms and interventions

Farrell, K., & Antoni, M. H. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.03.081 · Cited by 209

Depression as a systemic syndrome: mapping the feedback loops of major depressive disorder

Wittenborn, A. K., Rahmandad, H., Rick, J., & Hosseinichimeh, N. (2016) · Psychological Medicine · doi:10.1017/s0033291715002044 · Cited by 207

Potential applications for biguanides in oncology

Pollak, M. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67232 · Cited by 194

Metformin and Prostate Cancer: Reduced Development of Castration-resistant Disease and Prostate Cancer Mortality

Spratt, D. E., Zhang, C., Zumsteg, Z. S., Pei, X., Zhang, Z., & Zeléfsky, M. J. (2012) · European Urology · doi:10.1016/j.eururo.2012.12.004 · Cited by 184

Carotid artery intima-media thickness in polycystic ovary syndrome: a systematic review and meta-analysis

Meyer, M. L., Malek, A. M., Wild, R. A., Korytkowski, M. T., & Talbott, E. O. (2012) · Human Reproduction Update · doi:10.1093/humupd/dmr046 · Cited by 175

Review: Role of metformin in the management of polycystic ovary syndrome

Lashen, H. (2010) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018810380215 · Cited by 181

Novel Role of the SIRT1 in Endocrine and Metabolic Diseases

Lu, C., Zhao, H., Liu, Y., Yang, Z., Yao, H., Liu, T., Gou, T., Wang, L., Zhang, J., Tian, Y., et al. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.78654 · Cited by 160

Use of metformin in polycystic ovary syndrome

Mathur, R., Alexander, C. J., Yano, J., Trivax, B., & Azziz, R. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2008.09.010 · Cited by 150

The Future of Thiazolidinedione Therapy in the Management of Type 2 Diabetes Mellitus

Yau, H., Rivera, K., Lomonaco, R., & Cusi, K. J. (2013) · Current Diabetes Reports · doi:10.1007/s11892-013-0378-8 · Cited by 143

The effects of metformin with lifestyle therapy in polycystic ovary syndrome: a randomized double-blind study

Ladson, G., Dodson, W. C., Sweet, S. D., Archibong, A. E., Kunselman, A. R., Demers, L. M., Williams, N. I., Coney, P., & Legro, R. S. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.12.002 · Cited by 138

Phase II study of medroxyprogesterone acetate plus metformin as a fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer

Mitsuhashi, A., Sato, Y., Kiyokawa, T., Koshizaka, M., Hanaoka, H., & Shozu, M. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv539 · Cited by 136

Is it Time to Test Metformin in Breast Cancer Clinical Trials?

Cazzaniga, M., Bonanni, B., Guerrieri‐Gonzaga, A., & DeCensi, A. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0871 · Cited by 134

Higher serum testosterone concentration in older women is associated with insulin resistance, metabolic syndrome, and cardiovascular disease

Patel, S. M., Ratcliffe, S. J., Reilly, M. P., Weinstein, R., Bhasin, S., Blackman, M. R., Cauley, J. A., Sutton-Tyrrell, K., Robbins, J., Fried, L. P., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0740 · Cited by 132

Six Novel Susceptibility Loci for Early-Onset Androgenetic Alopecia and Their Unexpected Association with Common Diseases

Li, R., Brockschmidt, F. F., Kiefer, A. K., Stefánsson, H., Nyholt, D. R., Song, K. S., Vermeulen, S. H. H. M., Kanoni, S., Glass, D., Medland, S. E., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002746 · Cited by 128

Diagnostics and treatment of non-alcoholic fatty liver disease: clinical guidelines of the Russian Scientific Liver Society and the Russian gastroenterological association

Ivashkin, V. T., Mayevskaya, M. V., Pavlov, C. S., Тихонов, И. Н., Shirokova, E. N., Buyeverov, A. O., Drapkina, O. M., Shulpekova, Y. O., Tsukanov, V. V., Mammayev, S. N., et al. (2016) · Russian Journal of Gastroenterology Hepatology Coloproctology · doi:10.22416/1382-4376-2016-26-2-24-42 · Cited by 125

Pregnancy after bariatric surgery: a narrative literature review and discussion of impact on pregnancy management and outcome

Falcone, V., Linder, T., Feichtinger, M., Kiss, H., Eppel, W., Husslein, P. W., Prager, G., & Göbl, C. S. (2018) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-018-2124-3 · Cited by 122

Metformin accumulation: Lactic acidosis and high plasmatic metformin levels in a retrospective case series of 66 patients on chronic therapy

Vecchio, S., Giampreti, A., Petrolini, V. M., Lonati, D., Protti, A., Papa, P., Rognoni, C., Valli, A., Rocchi, L., Rolandi, L., et al. (2013) · Clinical Toxicology · doi:10.3109/15563650.2013.860985 · Cited by 122

The effects of old, new and emerging medicines on metabolic aberrations in PCOS

Bargiota, Α., & Diamanti‐Kandarakis, E. (2012) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018812437355 · Cited by 120

The mechanism of action of oral antidiabetic drugs: A review of recent literature

Bösenberg, L. H., & Zyl, D. G. V. (2008) · Journal of Endocrinology Metabolism and Diabetes of South Africa · doi:10.1080/22201009.2008.10872177 · Cited by 120

Efficacy and safety of metformin during pregnancy in women with gestational diabetes mellitus or polycystic ovary syndrome: a systematic review

Lautatzis, M.-E., Goulis, D. G., & Vrontakis, M. (2013) · Metabolism · doi:10.1016/j.metabol.2013.06.006 · Cited by 113

Metformin in polycystic ovary syndrome

Diamanti‐Kandarakis, E., Economou, F., Palimeri, S., & Christakou, C. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05679.x · Cited by 109

Reflections on inositol(s) for PCOS therapy: steps toward success

Nestler, J. E., & Unfer, V. (2015) · Gynecological Endocrinology · doi:10.3109/09513590.2015.1054802 · Cited by 106

Inositol as putative integrative treatment for PCOS

Genazzani, A. D. (2016) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2016.08.024 · Cited by 106

Metformin-like antidiabetic, cardio-protective and non-glycemic effects of naringenin: Molecular and pharmacological insights

Nyane, N. A., Tlaila, T. B., Malefane, T. G., Ndwandwe, D. E., & Owira, P. M. O. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.03.042 · Cited by 101

Insulin sensitiser agents alone and in co-treatment with r-FSH for ovulation induction in PCOS women

Raffone, E., Rizzo, P., & Benedetto, V. (2010) · Gynecological Endocrinology · doi:10.3109/09513590903366996 · Cited by 100

Clomiphene citrate, metformin or both as first‐step approach in treating anovulatory infertility in patients with polycystic ovary syndrome (PCOS): a systematic review of head‐to‐head randomized controlled studies and meta‐analysis

Palomba, S., Pasquali, R., Orio, F., & Nestler, J. E. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03369.x · Cited by 103

Pediatric obesity: Current concepts

Greydanus, D. E., Agana, M. G., Kamboj, M. K., Shebrain, S., Soares, N. S., Eke, R., & Patel, D. R. (2018) · Disease-a-Month · doi:10.1016/j.disamonth.2017.12.001 · Cited by 104

Serum AMH levels and insulin resistance in women with PCOS

Şahmay, S., Mathyk, B. A., Sofiyeva, N., Atakul, N., Azemi, A., & Erel, C. T. (2018) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2018.03.007 · Cited by 93

Lifestyle intervention and anti-obesity therapies in the polycystic ovary syndrome: impact on metabolism and fertility

Panidis, D., Tziomalos, K., Papadakis, E., Vosnakis, C., Chatzis, P., & Katsikis, I. (2013) · Endocrine · doi:10.1007/s12020-013-9971-5 · Cited by 93

Efficacy of myo-inositol in the treatment of cutaneous disorders in young women with polycystic ovary syndrome

Zacchè, M. M., Caputo, L., Filippis, S., Zacchè, G., Dindelli, M., & Ferrari, A. G. (2009) · Gynecological Endocrinology · doi:10.1080/09513590903015544 · Cited by 91

Metformin Ameliorates Uterine Defects in a Rat Model of Polycystic Ovary Syndrome

Zhang, Y., Hu, M., Meng, F., Sun, X., Xu, H., Zhang, J., Cui, P., Morina, N., Li, X., Li, W., et al. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.03.023 · Cited by 90

Long-term outcomes of progestin plus metformin as a fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer patients

Mitsuhashi, A., Habu, Y., Kobayashi, T., Kawarai, Y., Ishikawa, H., Usui, H., & Shozu, M. (2019) · Journal of Gynecologic Oncology · doi:10.3802/jgo.2019.30.e90 · Cited by 88

Hidradenitis Suppurativa Is Associated with Polycystic Ovary Syndrome: A Population-Based Analysis in the United States

Garg, A., Neuren, E., & Strunk, A. (2018) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2018.01.009 · Cited by 86

Clinical, metabolic, and endocrine parameters in response to metformin and lifestyle intervention in women with polycystic ovary syndrome: a randomized, double-blind, and placebo control trial

Fux Otta, C., Wior, M., Iraci, G. S., Kaplan, R., Torres, D., Gaido, M. I., & Wyse, E. P. (2010) · Gynecological Endocrinology · doi:10.3109/09513590903215581 · Cited by 85

TLR4-Associated IRF-7 and NFκB Signaling Act as a Molecular Link Between Androgen and Metformin Activities and Cytokine Synthesis in the PCOS Endometrium

Hu, M., Zhang, Y., Li, X., Cui, P., Sferruzzi-Perri, A. N., Brännström, M., Shao, R., & Billig, H. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa951 · Cited by 86

Mini-Special Issue paper Management of diabetic patients with hypoglycemic agents Metformin and its clinical use: new insights for an old drug in clinical practice

Cicero, A. F. G., Tartagni, E., & Ertek, S. (2012) · Archives of Medical Science · doi:10.5114/aoms.2012.31622 · Cited by 83

Metformin in therapeutic applications in human diseases: its mechanism of action and clinical study

Du, Y., Zhu, Y., Zhou, Y., Ding, J., & Liu, J. (2022) · Molecular Biomedicine · doi:10.1186/s43556-022-00108-w · Cited by 84

The effect of metformin on apoptosis in a breast cancer presurgical trial

Cazzaniga, M. E., DeCensi, A., Pruneri, G., Puntoni, M., Bottiglieri, L., Varricchio, C., Guerrieri‐Gonzaga, A., ­Gentilini, O., Pagani, G., Dell’Orto, P., et al. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.657 · Cited by 81

Role of Metformin in Polycystic Ovary Syndrome (PCOS): Related Infertility

Attia, G. M., Almouteri, M. M., & Alnakhli, F. T. (2023) · Cureus · doi:10.7759/cureus.44493 · Cited by 100

Differential Expression Patterns of Glycolytic Enzymes and Mitochondria-Dependent Apoptosis in PCOS Patients with Endometrial Hyperplasia, an Early Hallmark of Endometrial Cancer, In Vivo and the Impact of Metformin In Vitro

Wang, T., Zhang, J., Hu, M., Zhang, Y., Cui, P., Li, X., Li, J., Vestin, E., Brännström, M., Shao, R., et al. (2019) · International Journal of Biological Sciences · doi:10.7150/ijbs.31425 · Cited by 77

Greek hyperinsulinemic women, with or without polycystic ovary syndrome, display altered inositols metabolism

Baillargeon, J., Nestler, J. E., Ostlund, R. E., Apridonidze, T., & Diamanti‐Kandarakis, E. (2008) · Human Reproduction · doi:10.1093/humrep/den097 · Cited by 77

Improvement of endothelial function with metformin and rosiglitazone treatment in women with polycystic ovary syndrome

Jensterle, M., Šebeštjen, M., Janež, A., Preželj, J., Kocjan, T., Keber, I., & Pfeifer, M. (2008) · European Journal of Endocrinology · doi:10.1530/eje-08-0507 · Cited by 76

Metformin augments the levels of molecules that regulate the expression of the insulin-dependent glucose transporter GLUT4 in the endometria of hyperinsulinemic PCOS patients

Carvajal, R., Rosas, C., Kohan, K., Gabler, F., Vantman, D., Romero, C., & Vega, M. (2013) · Human Reproduction · doi:10.1093/humrep/det116 · Cited by 76

The impact of oral contraceptives and metformin on anti-Müllerian hormone serum levels in women with polycystic ovary syndrome and biochemical hyperandrogenemia

Panidis, D., Georgopoulos, N. A., Piouka, A., Katsikis, I., Saltamavros, A. D., Decavalas, G., & Diamanti‐Kandarakis, E. (2010) · Gynecological Endocrinology · doi:10.3109/09513590.2010.507283 · Cited by 71

Inositol: history of an effective therapy for Polycystic Ovary Syndrome.

Bizzarri, M., & Carlomagno, G. (2014) · PubMed · Cited by 71

Prevalence of polycystic ovary syndrome in young women who had idiopathic central precocious puberty

Franceschi, R., Gaudino, R., Marcolongo, A., Gallo, M. C., Rossi, L., Antoniazzi, F., & Tatò, L. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.11.016 · Cited by 70

Metformin in the treatment of infertility in polycystic ovarian syndrome: an alternative perspective

Nestler, J. E. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.04.073 · Cited by 71

Direct effects of metformin in the endometrium: a hypothetical mechanism for the treatment of women with PCOS and endometrial carcinoma

Shao, R., Li, X., Feng, Y., Lin, J.-F., & Billig, H. (2014) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-33-41 · Cited by 66

Effect of Different Doses of Metformin on Serum Testosterone and Insulin in Non-Diabetic Women With Breast Cancer: A Randomized Study

Campagnoli, C., Pasanisi, P., Abbà, C., Ambroggio, S., Biglia, N., Brucato, T., Colombero, R., Danese, S., Donadio, M., Venturelli, E., et al. (2012) · Clinical Breast Cancer · doi:10.1016/j.clbc.2012.03.004 · Cited by 66

Pregnancy outcomes and the effect of metformin treatment in women with polycystic ovary syndrome: an overview

Ghazeeri, G. S., Nassar, A. H., Younes, Z. M. H., & Awwad, J. T. (2012) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/j.1600-0412.2012.01385.x · Cited by 66

Metformin Therapy in Autosomal Dominant Polycystic Kidney Disease: A Feasibility Study

Brosnahan, G., Wang, W., Gitomer, B. Y., Struemph, T., George, D. M., You, Z., Nowak, K. L., Klawitter, J., & Chonchol, M. B. (2021) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2021.06.026 · Cited by 59

Characteristics of Adolescents Presenting to a Multidisciplinary Clinic for Polycystic Ovarian Syndrome

Bekx, M. T., Connor, E. L., & Allen, D. B. (2009) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2009.04.004 · Cited by 58

Hyperinsulinaemic androgen excess in adolescent girls

Ibáñez, L., Ong, K. K., López-Bermejo, A., Dunger, D. B., & de Zegher, F. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.58 · Cited by 56

Benefits of short-term structured exercise in non-overweight women with polycystic ovary syndrome: a prospective randomized controlled study

Turan, V., Mutlu, E. K., Solmaz, U., Ekin, A., Tosun, O., Tosun, G., Mat, E., Gezer, C., & Malkoc, M. (2015) · Journal of Physical Therapy Science · doi:10.1589/jpts.27.2293 · Cited by 55

PI3K: An Attractive Candidate for the Central Integration of Metabolism and Reproduction

Acosta‐Martínez, M. (2012) · Frontiers in Endocrinology · doi:10.3389/fendo.2011.00110 · Cited by 55

The androgen receptor confers protection against diet‐induced atherosclerosis, obesity, and dyslipidemia in female mice

Fagman, J. B., Wilhelmson, A. S., Motta, B. M., Pirazzi, C., Alexanderson, C., Gendt, K. D., Verhoeven, G., Holmäng, A. B., Anesten, F., Jansson, J., et al. (2014) · The FASEB Journal · doi:10.1096/fj.14-259234 · Cited by 55

Current perspectives of insulin resistance and polycystic ovary syndrome

Pauli, J. M., Raja-Khan, N. T., Wu, X., & Legro, R. S. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03460.x · Cited by 55

Reversing the reduced level of endometrial GLUT4 expression in polycystic ovary syndrome: a mechanistic study of metformin action.

Li, X., Cui, P., Jiang, H., Guo, Y.-R., Pishdari, B., Hu, M., Feng, Y., Billig, H., & Shao, R. (2015) · PubMed Central · Cited by 54

The effect of weight loss and treatment with metformin on serum vaspin levels in women with polycystic ovary syndrome

Koiou, E., Τζιόμαλος, Κ., Dinas, K. D., Katsikis, I., Kalaitzakis, E., Delkos, D., Kandaraki, E., & Panidis, D. (2011) · Endocrine Journal · doi:10.1507/endocrj.k10e-330 · Cited by 53

Systematic Review of Metformin Use in Obese Nondiabetic Children and Adolescents

Brufani, C., Crinò, A., Fintini, D., Patera, P. I., Cappa, M., & Manco, M. (2013) · Hormone Research in Paediatrics · doi:10.1159/000353760 · Cited by 55

Organic Cation Transporter 1 Polymorphisms Predict the Metabolic Response to Metformin in Women with the Polycystic Ovary Syndrome

Gambineri, A., Tomassoni, F., Gasparini, D. I., Rocco, A. D., Mantovani, V., Pagotto, U., Altieri, P., Sanna, S., Fulghesu, A. M., & Pasquali, R. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0145 · Cited by 53

The clinical significance of anti-Müllerian hormone evaluation in gynecological endocrinology

Karkanaki, A., Vosnakis, C., & Panidis, D. (2011) · HORMONES · doi:10.14310/horm.2002.1299 · Cited by 52

Use of metformin in the treatment of polycystic ovary syndrome

Genazzani, A. D., Ricchieri, F., & Lanzoni, C. (2010) · Women's Health · doi:10.2217/whe.10.43 · Cited by 51

Modeling the hypothalamus-pituitary-adrenal axis: A review and extension

Hosseinichimeh, N., Rahmandad, H., & Wittenborn, A. K. (2015) · Mathematical Biosciences · doi:10.1016/j.mbs.2015.08.004 · Cited by 51

Expedited development of a high dose orally disintegrating metformin tablet enabled by sweet salt formation with acesulfame

Wang, C., Hu, S., & Sun, C. C. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.08.100 · Cited by 51

Evaluation of endocrine changes in women with the polycystic ovary syndrome during metformin treatment

Velija-Ašimi, Z. (2013) · Bosnian Journal of Basic Medical Sciences · doi:10.17305/bjbms.2013.2359 · Cited by 49

Phenotypic expression, body mass index and insulin resistance in relation to LH levels in women with polycystic ovary syndrome

Katsikis, I., Karkanaki, A., Misichronis, G., Delkos, D., Kandaraki, E., & Panidis, D. (2011) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2011.01.023 · Cited by 48

Superior metabolic improvement of polycystic ovary syndrome traits after GLP1-based multi-agonist therapy

Sanchez-Garrido, M. A., Serrano-López, V., Ruíz-Pino, F., Vazquez, M. J., Rodríguez-Martín, A., Torres, E., Velasco, I., Rodríguez, A., Chicano‐Gálvez, E., Mora-Ortiz, M., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52898-y · Cited by 53

An RCT of metformin versus orlistat for the management of obese anovulatory women

Metwally, M., Amer, S. A. K. S., Li, T. C., & Ledger, W. J. (2008) · Human Reproduction · doi:10.1093/humrep/den454 · Cited by 46

Contemporary approaches to the management of polycystic ovary syndrome

Pasquali, R. (2018) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018818756790 · Cited by 49

Does the antidiabetic drug metformin affect embryo development and the health of brown trout (Salmo trutta f. fario)?

Jacob, S., Dötsch, A., Knoll, S., Köhler, H., Rogall, E. T., Stoll, D., Tisler, S., Hühn, C., Schwartz, T., Zwiener, C., et al. (2018) · Environmental Sciences Europe · doi:10.1186/s12302-018-0179-4 · Cited by 49

Metformin modulates IL-8, IL-1β, ICAM and IGFBP-1 expression in human endometrial stromal cells

Germeyer, A., Jauckus, J., Zorn, M., Tóth, B., Capp, E., & Strowitzki, T. (2010) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2010.11.006 · Cited by 44

Metformin Alleviates Endometriosis and Potentiates Endometrial Receptivity via Decreasing VEGF and MMP9 and Increasing Leukemia Inhibitor Factor and HOXA10

Cheng, J., Li, C., Ying, Y., Lv, J., Qu, X., McGowan, E. M., Lin, Y., & Zhu, X. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.750208 · Cited by 43

Targets to treat metabolic syndrome in polycystic ovary syndrome

Mahalingaiah, S., & Diamanti‐Kandarakis, E. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2015.1101067 · Cited by 44

Cardiovascular Disease Risk in Adult Women with Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency

Kim, M. S., & Merke, D. P. (2009) · Seminars in Reproductive Medicine · doi:10.1055/s-0029-1225259 · Cited by 41

Novel clomiphene “stair-step” protocol reduces time to ovulation in women with polycystic ovarian syndrome

Hurst, B. S., Hickman, J. M., Matthews, M. L., Usadi, R., & Marshburn, P. B. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2008.10.031 · Cited by 43

What every physician should know about polycystic ovary syndrome

Rosenfield, R. L. (2008) · Dermatologic Therapy · doi:10.1111/j.1529-8019.2008.00217.x · Cited by 42

Factors Contributing to Initial Weight Loss Among Adolescents with Polycystic Ovary Syndrome

Geier, L. M., Bekx, M. T., & Connor, E. L. (2012) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2012.06.008 · Cited by 40

Follicle stimulating hormone controls granulosa cell glutamine synthesis to regulate ovulation

Zhang, K.-H., Zhang, F., Zhang, Z., Fang, K.-F., Sun, W.-X., Kong, N., Wu, M., Liu, H., Liu, Y., Li, Z., et al. (2024) · Protein & Cell · doi:10.1093/procel/pwad065 · Cited by 40

Comparison of glycemic control and β-cell function in new onset T2DM patients with PCOS of metformin and saxagliptin monotherapy or combination treatment

Tao, T., Wu, P., Wang, Y., & Liu, W. (2018) · BMC Endocrine Disorders · doi:10.1186/s12902-018-0243-5 · Cited by 38

Alterations of endometrial epithelial–mesenchymal transition and MAPK signalling components in women with PCOS are partially modulated by metformin in vitro

Hu, M., Zhang, Y., Li, X., Cui, P., Li, J., Brännström, M., Shao, R., & Billig, H. (2020) · Molecular Human Reproduction · doi:10.1093/molehr/gaaa023 · Cited by 38

Update on the therapeutic effects of metformin in the treatment of polycystic ovary syndrome

Wu, Y., & Liu, C. (2010) · Intern J Endocrinol Metab · doi:10.3760/cma.j.issn.1673-4157.2010.04.012

Metformin and polycystic ovary syndrome

Lebinger, T. G. (2007) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e328089f0ea · Cited by 13

[Metformin for the treatment of polycystic ovary syndrome].

Pekhlivanov, B., & Mitkov, M. (2005) · PubMed

How to correctly understand the effect of metformin in the treatment of polycystic ovary syndrome

Kellis, M. (2012) · Zhonghua neifenmi daixie zazhi · doi:10.3760/cma.j.issn.1000-6699.2012.08.001

Metformin and Polycystic Ovary Syndrome: A Literature Review

Awartani, K. A., & Cheung, A. P. (2002) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(16)30402-9 · Cited by 31